BCTG Avocats has advised PathoQuest, a leader in RX Next-Generation Sequencing (NGS) solutions for biosafety testing, in connection with its entry into a definitive agreement to join Charles River Laboratories (CRL).

The BCTG team was led by Severin Kullmann and Willy Mathot, with Paul Truck and Paul Leconte.

Find out more about the deal in PathoQuest’s press release here.